What is CKD?
abnormalities of kidney structure or function present for >3 months with implications for health
How is CKD classified?
What is End Stage Renal Disease (ESRD)?
What are risk factors for developing CKD?
What are socioeconomic risk factors for CKD?
What are risk factors for progression of CKD?
When does CKD presentation usually occur?
asymptomatic until significant amount of renal function lost CKD stage 4/5
What are labs indicate CKD?
What are signs of CKD?
What are the uremic symptoms associated with CKD?
What are nonpharm treatments of CKD?
What are pharm treatments for CKD?
When should proteinuria (albuminuria) be treated?
stage A2 or higher
What is first line treatment for stage A2 or higher albuminuria?
low dose (2.5-5mg) ACEi or ARB
What patients should ACEs and ARBs be used in caution with?
When should the dose of ACE/ARB not be titrated up in CKD?
What should be added if patient is on max tolerated ACE/ARB and ARC>300?
SGLT2i:
Empagliflozin JARDIANCE 10mg QD
Dapagliflozin FARXIGA 10mg QD
What is first line treatment for stage A2 or higher AND HTN?
low dose (2.5-5mg) ACEi or ARB, once albumin excretion <30mg/24h or decreases 30-50% target a systolic BP of </=120mmHg
What is the BP goal for kidney transplant patients with stage A2 or higher AND HTN?
</=130/80
What can be added to achieve a BP goal of <120mmHg
What is the treatment for stage A2 and T2DM?
When should Metformin regimens be reviewed and discontinued?
review: GFR 30-45 (lactic acidosis vs. A1c goal)
D/C: GFR <30
What can be used as an adjunctive agent for patients with persistently elevated albuminuria (ACR >30) and are receiving other preferred therapies?
Finerenone KERENDIA 10-20mg QD
What is the MOA of Finerenone?
non-steroidal selective mineralocorticoid receptor antagonist; mediates sodium reabsorption and over-activation in epithelial(kidney) and nonepithelial cells(vessels,heart)